Consolidated statements of changes in equity
(unaudited)
(thousands of €) |
Share |
Share |
Translation |
Other |
Accumul. |
Total |
On 1 January 2017 |
223,928 |
649,135 |
(1,090) |
(1,000) |
(112,272) |
758,701 |
Net loss |
|
|
|
|
(85,855) |
(85,855) |
Other comprehensive income |
|
|
(569) |
(62) |
|
(631) |
Total comprehensive income |
|
|
(569) |
(62) |
(85,855) |
(86,486) |
Share-based compensation |
|
|
|
|
11,697 |
11,697 |
Issue of new shares |
23,331 |
340,593 |
|
|
|
363,924 |
Share issue costs |
(15,837) |
|
|
|
|
(15,837) |
Exercise of warrants |
1,770 |
3,165 |
|
|
|
4,935 |
On 30 September 2017 |
233,192 |
992,893 |
(1,659) |
(1,062) |
(186,432) |
1,036,932 |
|
|
|
|
|
|
|
On 31 December 2017 |
233,414 |
993,025 |
(1,754) |
(1,260) |
(211,441) |
1,011,983 |
Change in accounting policy (modified retrospective application IFRS 15) |
|
|
|
|
(83,220) |
(83,220) |
Change in accounting policy (modified retrospective application IFRS 9) |
|
|
|
619 |
(619) |
– |
Restated total equity at 1 January 2018 |
233,414 |
993,025 |
(1,754) |
(641) |
(295,280) |
928,764 |
Net loss |
|
|
|
|
(44,215) |
(44,215) |
Other comprehensive income |
|
|
156 |
– |
|
156 |
Total comprehensive income |
|
|
156 |
– |
(44,215) |
(44,059) |
Share-based compensation |
|
|
|
|
18,001 |
18,001 |
Issue of new shares |
16,021 |
280,167 |
|
|
|
296,188 |
Share issue costs |
(15,932) |
|
|
|
|
(15,932) |
Exercise of warrants |
2,169 |
3,092 |
|
|
|
5,261 |
On 30 September 2018 |
235,672 |
1,276,284 |
(1,598) |
(641) |
(321,495) |
1,188,222 |
The accompanying notes form an integral part of these condensed consolidated financial statements.